齐米工厂发布了ZW191癌症药物的第一阶段数据. Zymeworks releases Phase 1 data for ZW191 cancer drug at AACR.

齐米公司发布了ZW191的第一阶段临床试验新数据,该药物旨在向表达叶酸受体α的癌细胞. Zymeworks Inc. has released new data from a Phase 1 clinical trial of ZW191, a drug designed to target cancer cells expressing Folate Receptor Alpha. 这些发现在AACR年会上发表,提供了关于该药物治疗癌症的安全性和有效性的最新信息. The findings were presented at the AACR Annual Meeting, providing updates on the drug's safety and effectiveness in treating cancer.